Sue Brown
5
2
2
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
20.0%
1 terminated/withdrawn out of 5 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
100%
1 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)
Role: lead
A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home)
Role: lead
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
Role: lead
Adaptive Biobehavioral Control (ABC) in a Closed-Loop System
Role: lead
Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes
Role: lead
All 5 trials loaded